glp 1 agonist nash Full article: GLP-1 receptor agonists in the treatment of diabetic non–alcoholic steatohepatitis patients Emerging Role of GLP-1 Receptor

This stepwise approach significantly reduces gastrointestinal side effects

Glucagon-like peptide-1 and its class BG proteincoupled receptors: a long march to therapeutic successes

1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties

Government Support and Policy Initiatives Recognizing the need for accessible obesity treatments, India plans to offer incentives under the Production Linked Incentive (PLI) scheme to promote the local manufacturing of GLP-1 drugs in 2026

While these drugs have gained increased attention in the past decade, GLP-1, as a hormone, was first identified in the eighties

ACOG Practice Bulletin, Number 230